56 datasets found
  1. Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER)...

    • catalog.data.gov
    • healthdata.gov
    • +2more
    Updated Jul 26, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (NCI), National Institutes of Health (NIH) (2023). Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use [Dataset]. https://catalog.data.gov/dataset/cancer-incidence-surveillance-epidemiology-and-end-results-seer-registries-limited-use
    Explore at:
    Dataset updated
    Jul 26, 2023
    Dataset provided by
    National Cancer Institutehttp://www.cancer.gov/
    Description

    SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute collects and distributes high quality, comprehensive cancer data from a number of population-based cancer registries. Data include patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage.

  2. a

    NCI State Cancer Incidence Rates

    • hub.arcgis.com
    Updated Aug 20, 2019
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (2019). NCI State Cancer Incidence Rates [Dataset]. https://hub.arcgis.com/datasets/NCI::nci-state-cancer-incidence-rates
    Explore at:
    Dataset updated
    Aug 20, 2019
    Dataset authored and provided by
    National Cancer Institute
    License

    MIT Licensehttps://opensource.org/licenses/MIT
    License information was derived automatically

    Area covered
    Description

    This dataset contains Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2012 to 2016.Data is segmented by sex and age, with fields describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.gov Data NotationsState Cancer Registries may provide more current or more local data.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population seer.cancer.gov/stdpopulations/stdpop.19ages.html. Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. [seer.cancer.gov/seerstat]Population counts for denominators are based on Census populations as modified [seer.cancer.gov/popdata] by NCI. The 1969-2016 US Population Data File [seer.cancer.gov/popdata] is used for SEER and NPCR incidence rates.‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information. Rates and trends are computed using different standards for malignancy. For more information see malignant.html.^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage [seer.cancer.gov/tools/ssm].Healthy People 2020 Objectives [www.healthypeople.gov]provided by the Centers for Disease Control and Prevention [www.cdc.gov]. Michigan Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.Trend Data not available for Nevada.Data Source Field Key:(1) Source: CDC's National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS) November 2018 data submission and SEER November 2018 submission as published in United States Cancer Statistics nccd.cdc.gov/uscs Source: State Cancer Registry and the CDC's National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS) November 2018 data submission. State rates include rates from metropolitan areas funded by SEER [seer.cancer.gov/registries].(6) Source: State Cancer Registry and the CDC's National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS) November 2018 data submission.(7) Source: SEER November 2018 submission.8 Source: Incidence data provided by the SEER Program. [seer.cancer.gov] AAPCs are calculated by the Joinpoint Regression Program [surveillance.cancer.gov/joinpoint] and are based on APCs. Data are age-adjusted to the 2000 US standard population www.seer.cancer.gov/stdpopulations/single_age.html. Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data [seer.cancer.gov/popdata] File is used with SEER November 2018 data. Please note that the data comes from different sources. Due to different years [statecancerprofiles.cancer.gov/historicaltrend/differences.html] of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. [seer.cancer.gov/seerstat] Please refer to the source for each graph for additional information. Some data are not available [http://statecancerprofiles.cancer.gov/datanotavailable.html] for combinations of geography, cancer site, age, and race/ethnicity.

  3. NCI State Breast Cancer Incidence Rates

    • hub.arcgis.com
    Updated Jan 2, 2020
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (2020). NCI State Breast Cancer Incidence Rates [Dataset]. https://hub.arcgis.com/maps/NCI::nci-state-breast-cancer-incidence-rates
    Explore at:
    Dataset updated
    Jan 2, 2020
    Dataset authored and provided by
    National Cancer Institutehttp://www.cancer.gov/
    License

    MIT Licensehttps://opensource.org/licenses/MIT
    License information was derived automatically

    Area covered
    Description

    This dataset contains Cancer Incidence data for Breast Cancer (All Stages^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2016 to 2020.Data are for females segmented by age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.govData NotationsState Cancer Registries may provide more current or more local data.TrendRising when 95% confidence interval of average annual percent change is above 0.Stable when 95% confidence interval of average annual percent change includes 0.Falling when 95% confidence interval of average annual percent change is below 0.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.Rates and trends are computed using different standards for malignancy. For more information see malignant.^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.Data Source Field Key(1) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(5) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(6) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).(7) Source: SEER November 2022 submission.(8) Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2022 data.Some data are not available, see Data Not Available for combinations of geography, cancer site, age, and race/ethnicity.Data for the United States does not include data from Nevada.Data for the United States does not include Puerto Rico.

  4. f

    Table_1_Racial and regional disparities of triple negative breast cancer...

    • frontiersin.figshare.com
    docx
    Updated May 31, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Wei Zhang; Yuhui Bai; Caixing Sun; Zhangchun Lv; Shihua Wang (2023). Table_1_Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011–2019 NPCR and SEER incidence data.docx [Dataset]. http://doi.org/10.3389/fpubh.2022.1058722.s001
    Explore at:
    docxAvailable download formats
    Dataset updated
    May 31, 2023
    Dataset provided by
    Frontiers
    Authors
    Wei Zhang; Yuhui Bai; Caixing Sun; Zhangchun Lv; Shihua Wang
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    ObjectiveTriple negative breast cancer (TNBC) is a more aggressive subtype resistant to conventional treatments with a poorer prognosis. This study was to update the status of TNBC and the temporal changes of its incidence rate in the US.MethodsWomen diagnosed with breast cancer during 2011–2019 were obtained from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology and End Results (SEER) Program SEER*Stat Database which covers the entire population of the US. The TNBC incidence and its temporal trends by race, age, region (state) and disease stage were determined during the period.ResultsA total of 238,848 (or 8.8%) TNBC women were diagnosed during the study period. TNBC occurred disproportionally higher in women of Non-Hispanic Black, younger ages, with cancer at a distant stage or poorly/undifferentiated. The age adjusted incidence rate (AAIR) for TNBC in all races decreased from 14.8 per 100,000 in 2011 to 14.0 in 2019 (annual percentage change (APC) = −0.6, P = 0.024). Incidence rates of TNBC significantly decreased with APCs of −0.8 in Non-Hispanic White women, −1.3 in West and −0.7 in Northeastern regions. Women with TNBC at the age of 35–49, 50–59, and 60–69 years, and the disease at the regional stage displayed significantly decreased trends. Among state levels, Mississippi (20.6) and Louisiana (18.9) had the highest, while Utah (9.1) and Montana (9.6) had the lowest AAIRs in 2019. New Hampshire and Indiana had significant and highest decreases, while Louisiana and Arkansas had significant and largest increases in AAIR. In individual races, TNBC displayed disparities in temporal trends among age groups, regions and disease stages. Surprisingly, Non-Hispanic White and Hispanic TNBC women (0–34 years), and Non-Hispanic Black women (≥70 years) during the entire period, as well as Asian or Pacific Islander women in the South region had increased trends between 2011 and 2017.ConclusionOur study demonstrates an overall decreased trend of TNBC incidence in the past decade. Its incidence displayed disparities among races, age groups, regions and disease stages. Special attention is needed for a heavy burden in Non-Hispanic Black and increased trends in certain groups.

  5. NCI State Lung Cancer Incidence Rates

    • arc-gis-hub-home-arcgishub.hub.arcgis.com
    • hub.arcgis.com
    Updated Jan 2, 2020
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (2020). NCI State Lung Cancer Incidence Rates [Dataset]. https://arc-gis-hub-home-arcgishub.hub.arcgis.com/datasets/NCI::nci-state-lung-cancer-incidence-rates/about
    Explore at:
    Dataset updated
    Jan 2, 2020
    Dataset authored and provided by
    National Cancer Institutehttp://www.cancer.gov/
    License

    MIT Licensehttps://opensource.org/licenses/MIT
    License information was derived automatically

    Area covered
    Description

    This dataset contains Cancer Incidence data for Lung Cancer (All Stages^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2016 to 2020.Data are segmented by sex (Both Sexes, Male, and Female) and age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.govData NotationsState Cancer Registries may provide more current or more local data.TrendRising when 95% confidence interval of average annual percent change is above 0.Stable when 95% confidence interval of average annual percent change includes 0.Falling when 95% confidence interval of average annual percent change is below 0.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.Rates and trends are computed using different standards for malignancy. For more information see malignant.^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.Data Source Field Key(1) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(5) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(6) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).(7) Source: SEER November 2022 submission.(8) Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2022 data.Some data are not available, see Data Not Available for combinations of geography, cancer site, age, and race/ethnicity.Data for the United States does not include data from Nevada.Data for the United States does not include Puerto Rico.

  6. f

    Table_5_Racial Disparities and Sex Differences in Early- and Late-Onset...

    • frontiersin.figshare.com
    xlsx
    Updated Jun 9, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Jessica L. Petrick; Lauren E. Barber; Shaneda Warren Andersen; Andrea A. Florio; Julie R. Palmer; Lynn Rosenberg (2023). Table_5_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx [Dataset]. http://doi.org/10.3389/fonc.2021.734998.s010
    Explore at:
    xlsxAvailable download formats
    Dataset updated
    Jun 9, 2023
    Dataset provided by
    Frontiers
    Authors
    Jessica L. Petrick; Lauren E. Barber; Shaneda Warren Andersen; Andrea A. Florio; Julie R. Palmer; Lynn Rosenberg
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    BackgroundColorectal cancer (CRC) incidence rates have increased in younger individuals worldwide. We examined the most recent early- and late-onset CRC rates for the US.MethodsAge-standardized incidence rates (ASIR, per 100,000) of CRC were calculated using the US Cancer Statistics Database’s high-quality population-based cancer registry data from the entire US population. Results were cross-classified by age (20-49 [early-onset] and 50-74 years [late-onset]), race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, American Indian/Alaskan Native, Asian/Pacific Islander), sex, anatomic location (proximal, distal, rectal), and histology (adenocarcinoma, neuroendocrine).ResultsDuring 2001 through 2018, early-onset CRC rates significantly increased among American Indians/Alaskan Natives, Hispanics, and Whites. Compared to Whites, early-onset CRC rates are now 21% higher in American Indians/Alaskan Natives and 6% higher in Blacks. Rates of early-onset colorectal neuroendocrine tumors have increased in Whites, Blacks, and Hispanics; early-onset colorectal neuroendocrine tumor rates are 2-times higher in Blacks compared to Whites. Late-onset colorectal adenocarcinoma rates are decreasing, while late-onset colorectal neuroendocrine tumor rates are increasing, in all racial/ethnic groups. Late-onset CRC rates remain 29% higher in Blacks and 15% higher in American Indians/Alaskan Natives compared to Whites. Overall, CRC incidence was higher in men than women, but incidence of early-onset distal colon cancer was higher in women.ConclusionsThe early-onset CRC disparity between Blacks and Whites has decreased, due to increasing rates in Whites—rates in Blacks have remained stable. However, rates of colorectal neuroendocrine tumors are increasing in Blacks. Blacks and American Indians/Alaskan Natives have the highest rates of both early- and late-onset CRC.ImpactOngoing prevention efforts must ensure access to and uptake of CRC screening for Blacks and American Indians/Alaskan Natives.

  7. w

    Late-Stage Female Breast Cancer Incidence Rate (cases per 100,000 females),...

    • data.wu.ac.at
    • healthdata.nj.gov
    Updated May 16, 2018
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Loretta Kelly (2018). Late-Stage Female Breast Cancer Incidence Rate (cases per 100,000 females), New Jersey, by year: Beginning 2010 [Dataset]. https://data.wu.ac.at/odso/healthdata_nj_gov/OXp6dy1iemV4
    Explore at:
    Dataset updated
    May 16, 2018
    Dataset provided by
    Loretta Kelly
    Area covered
    New Jersey
    Description

    Rate: Number of new cases of breast cancer (per 100,000) diagnosed at the regional or distant stage among females.

    Definition: Age-adjusted incidence rate of invasive breast cancer per 100,000 female population.

    Data Sources:

    (1) NJ State Cancer Registry, Dec 31, 2015 Analytic File, using NCI SEER*Stat ver 8.2.1 (www.seer.cancer.gov/seerstat)

    (2) NJ population estimates as calculated by the NCI's SEER Program, released January 2015, http://www.seer.cancer.gov/popdata/download.html.

  8. f

    Trend analysis of major cancer statistics according to sex and severity...

    • plos.figshare.com
    docx
    Updated Jun 1, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Minsu Ock; Woong Jae Choi; Min-Woo Jo (2023). Trend analysis of major cancer statistics according to sex and severity levels in Korea [Dataset]. http://doi.org/10.1371/journal.pone.0203110
    Explore at:
    docxAvailable download formats
    Dataset updated
    Jun 1, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Minsu Ock; Woong Jae Choi; Min-Woo Jo
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    South Korea
    Description

    Existing epidemiologic reports or studies of cancer statistics in Korea lack sufficient data on cancer severity distributions and observed survival rates. This study analyzed trends in major cancer statistics according to sex and severity levels in Korea from 2006 to 2013. We included eight cancers (hepatocellular carcinoma, and thyroid, colorectal, gastric, lung, prostate, breast, and cervical cancer), using Korea Central Cancer Registry data. Severity level was classified by Surveillance, Epidemiology, and End Results (SEER) stage as follows: localized, regional, distant, or unknown. Numbers of incident cancer cases from 2006 to 2013 were described by sex and SEER stage. We estimated up to 8-year observed survival rates of major cancers by sex and SEER stage, and provided prevalence rates by sex and SEER stage in 2011, 2012, and 2013. Although increases in new cancer cases are slowing and the total number of incident cancer cases in 2013 decreased for the first time since 2006, the number of prevalent cancer cases was 663,530 in 2013, an increase of 13.3% compared to 2011. Among the five cancers affecting both sexes, sex-related differences in 5-year observed survival rates for lung cancer were greatest in the localized stage (men, 31.9%; women, 48.1%), regional stage (men, 20.0%; women, 31.3%), and unknown stage (men, 24.3%; women, 37.5%). The sum of the proportions of localized and regional stages for thyroid and breast cancer was over 90% in 2013, while the sum of the proportions of localized and regional stages for lung cancer was only 56.7% in 2013. Differences in observed survival rates between men and women were prominent in lung cancer for all SEER stages. The reported epidemiologic data from this study can be used to obtain a more valid measure of cancer burden using a summary measure of population health.

  9. Incidence rates and incidence rate ratios (IRR) per 10 million population.

    • plos.figshare.com
    xls
    Updated May 31, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Alexandra Rizzitelli; Nicolas R. Smoll; Michael P. Chae; Warren M. Rozen; David J. Hunter-Smith (2023). Incidence rates and incidence rate ratios (IRR) per 10 million population. [Dataset]. http://doi.org/10.1371/journal.pone.0117789.t002
    Explore at:
    xlsAvailable download formats
    Dataset updated
    May 31, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Alexandra Rizzitelli; Nicolas R. Smoll; Michael P. Chae; Warren M. Rozen; David J. Hunter-Smith
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Data obtained from SEER 9 registries.* p<0.05.N/A, not-applicable.Incidence rates and incidence rate ratios (IRR) per 10 million population.

  10. f

    Data from: Nationwide incidence and survival of retinoblastoma in the USA...

    • tandf.figshare.com
    pdf
    Updated May 12, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Ahmad Samir Alfaar; Hadeel Halalsheh; Abdallah E. Shelil; Ibrahim Qaddoumi (2025). Nationwide incidence and survival of retinoblastoma in the USA between 1996 and 2018: a review of 5730 cases [Dataset]. http://doi.org/10.6084/m9.figshare.28381058.v1
    Explore at:
    pdfAvailable download formats
    Dataset updated
    May 12, 2025
    Dataset provided by
    Taylor & Francis
    Authors
    Ahmad Samir Alfaar; Hadeel Halalsheh; Abdallah E. Shelil; Ibrahim Qaddoumi
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    Retinoblastoma is the most common intraocular cancer in children, with significant variations in incidence and Survival. This study sought to evaluate nationwide retinoblastoma incidences and survival rates in the United States from 1996 to 2018. We extracted data from the North American Association of Central Cancer Registries (NACCR) and the National Program of Cancer Registries between 1996 and 2018. Cases were stratified by sex, age, race, Hispanic origin, urban or rural origin, stage of the disease, and state of residence and compared by laterality. We applied SEER*Stat version 8.4.0.1 software for age-adjusted incidence rates (AAIR) and annual average per cent change (AAPC) and JoinPoint version 4.9.1.0 software to assess incidence trends. Survival trends were evaluated with JPSurv online software. The study comprised 5730 patients with a crude incidence rate (CIR) of 0.89 per million. The incidence declined from 29.6 per million in the first year of life to 16.5 in the second year. The CIR for unilateral and bilateral diseases were 0.61 and 0.27, respectively. Males had a slightly higher and significant crude incidence of 0.93 versus 0.86 for females. Hispanics had the highest rate of 1.48 in general. Treatment data revealed chemotherapy usage in 39% of unilateral and 78% of bilateral patients. The 5-year cumulative relative Survival did not significantly differ between unilateral (96.8%) and bilateral (97.0%) patients. A slight but significant annual decline in CIR was observed, with a trend toward an increase in the percentage of patients diagnosed in the first year of life. This study indicated an overall decrease in incidence but a slight increase in early diagnosis. Findings underscore the need for consistent surveillance, early detection strategies, and personalized care to improve patient outcomes. The changes in the Survival in the unilateral disease require further investigations and mitigation strategies.

  11. m

    A Geotemporospatial and Causal Inference Epidemiological Exploration of...

    • data.mendeley.com
    • researchdata.edu.au
    Updated Sep 8, 2020
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Albert Reece (2020). A Geotemporospatial and Causal Inference Epidemiological Exploration of Substance and Cannabinoid Exposure as Drivers of Rising US Pediatric Cancer Rates - Dataset [Dataset]. http://doi.org/10.17632/wft6gkhdyw.1
    Explore at:
    Dataset updated
    Sep 8, 2020
    Authors
    Albert Reece
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    Data support a paper of this title:

    A Geotemporospatial and Causal Inference Epidemiological Exploration of Substance and Cannabinoid Exposure as Drivers of Rising US Pediatric Cancer Rates

    Data represent a compilation of various data inputs from numerous sources including the National Cancer Institute SEER*Stat National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence – U.S. Cancer Statistics Public Use Research Database, 2019 submission (2001-2017), United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Released June 2020. Available at www.cdc.gov/cancer/public-use program; the National survey of Drug Use and Health conducted by the Substance Abuse and Mental Health Services Administration; and the US Census bureau.

    Data also include inverse probability weights for cannabis exposure.

    Data also include their geospatial linkage network constructed for all US states which makes Alaska and Hawaii spatially connected to the contiguous USA.

    Data also include the R script used to conduct and prepare the analysis.

  12. Cancer incidence trends, by sex and cancer type

    • www150.statcan.gc.ca
    • beta.data.urbandatacentre.ca
    • +2more
    Updated May 16, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Government of Canada, Statistics Canada (2023). Cancer incidence trends, by sex and cancer type [Dataset]. http://doi.org/10.25318/1310084001-eng
    Explore at:
    Dataset updated
    May 16, 2023
    Dataset provided by
    Statistics Canadahttps://statcan.gc.ca/en
    Area covered
    Canada
    Description

    Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

  13. Cancer Surveillance and Epidemiology in the United States and Puerto Rico,...

    • icpsr.umich.edu
    ascii
    Updated Feb 11, 1993
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    National Cancer Institute (U.S.) (1993). Cancer Surveillance and Epidemiology in the United States and Puerto Rico, 1973-1977 [Dataset]. http://doi.org/10.3886/ICPSR08001.v2
    Explore at:
    asciiAvailable download formats
    Dataset updated
    Feb 11, 1993
    Dataset provided by
    Inter-university Consortium for Political and Social Researchhttps://www.icpsr.umich.edu/web/pages/
    Authors
    National Cancer Institute (U.S.)
    License

    https://www.icpsr.umich.edu/web/ICPSR/studies/8001/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/8001/terms

    Time period covered
    1973 - 1977
    Area covered
    Puerto Rico, United States
    Description

    This dataset was produced as part of the Surveillance, Epidemiology, and End Results (SEER) Program to monitor the incidence of cancer and cancer survival rates in the United States, thus carrying out the mandates of the National Cancer Act. The SEER Program had several objectives: to estimate the annual cancer incidence in the United States, to examine trends in cancer patient survival, to identify cancer etiologic factors, and to monitor trends in the incidence of cancer in selected geographic areas with respect to demographic and social characteristics. Data collection began in 1973, and by 1977 had a population base of 11 geographic areas in the United States and Puerto Rico. SEER variables include patient demographic information (age, sex, race, birthplace, marital status, census tract) and information on cancer, which was gathered from hospitals, clinics, private laboratories, private practitioners, nursing/convalescent homes, autopsies, and death certificates. The medical data cover histologic type, anatomic site, laterality, multiplicity within primary site at first diagnosis, diagnostic procedures, diagnostic confirmation, sequence of the tumor, extent of the disease, treatment of the lesion, and outcome.

  14. G

    Number of new cases and age-standardized rates of primary cancer, by cancer...

    • ouvert.canada.ca
    • www150.statcan.gc.ca
    • +2more
    csv, html, xml
    Updated Feb 3, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statistics Canada (2025). Number of new cases and age-standardized rates of primary cancer, by cancer type and sex [Dataset]. https://ouvert.canada.ca/data/dataset/a1302774-b04c-4dc6-9b7e-7f827b8244ec
    Explore at:
    csv, html, xmlAvailable download formats
    Dataset updated
    Feb 3, 2025
    Dataset provided by
    Statistics Canada
    License

    Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
    License information was derived automatically

    Description

    The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

  15. a

    5 year Cancer Incidence MSSA

    • usc-geohealth-hub-uscssi.hub.arcgis.com
    Updated Nov 10, 2021
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Spatial Sciences Institute (2021). 5 year Cancer Incidence MSSA [Dataset]. https://usc-geohealth-hub-uscssi.hub.arcgis.com/items/8cdb67d331574191a32edb304e8055bf
    Explore at:
    Dataset updated
    Nov 10, 2021
    Dataset authored and provided by
    Spatial Sciences Institute
    Area covered
    Description

    Medical Service Study Areas (MSSAs)As defined by California's Office of Statewide Health Planning and Development (OSHPD) in 2013, "MSSAs are sub-city and sub-county geographical units used to organize and display population, demographic and physician data" (Source). Each census tract in CA is assigned to a given MSSA. The most recent MSSA dataset (2014) was used. Spatial data are available via OSHPD at the California Open Data Portal. This information may be useful in studying health equity.Age-Adjusted Incidence Rate (AAIR)Age-adjustment is a statistical method that allows comparisons of incidence rates to be made between populations with different age distributions. This is important since the incidence of most cancers increases with age. An age-adjusted cancer incidence (or death) rate is defined as the number of new cancers (or deaths) per 100,000 population that would occur in a certain period of time if that population had a 'standard' age distribution. In the California Health Maps, incidence rates are age-adjusted using the U.S. 2000 Standard Population.Cancer incidence ratesIncidence rates were calculated using case counts from the California Cancer Registry. Population data from 2010 Census and SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators. Yearly SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators for 5-year incidence rates (2013-2017)According to California Department of Public Health guidelines, cancer incidence rates cannot be reported if based on <15 cancer cases and/or a population <10,000 to ensure confidentiality and stable statistical rates.Spatial extent: CaliforniaSpatial Unit: MSSACreated: n/aUpdated: n/aSource: California Health MapsContact Email: gbacr@ucsf.eduSource Link: https://www.californiahealthmaps.org/?areatype=mssa&address=&sex=Both&site=AllSite&race=&year=05yr&overlays=none&choropleth=Obesity

  16. Incidence rate trend slopes.

    • plos.figshare.com
    • figshare.com
    xls
    Updated May 30, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Jessica Burkhamer; David Kriebel; Richard Clapp (2023). Incidence rate trend slopes. [Dataset]. http://doi.org/10.1371/journal.pone.0172986.t003
    Explore at:
    xlsAvailable download formats
    Dataset updated
    May 30, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Jessica Burkhamer; David Kriebel; Richard Clapp
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Incidence rate trend slopes.

  17. f

    The increasing toll of adolescent cancer incidence in the US

    • plos.figshare.com
    tiff
    Updated Jun 2, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Jessica Burkhamer; David Kriebel; Richard Clapp (2023). The increasing toll of adolescent cancer incidence in the US [Dataset]. http://doi.org/10.1371/journal.pone.0172986
    Explore at:
    tiffAvailable download formats
    Dataset updated
    Jun 2, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Jessica Burkhamer; David Kriebel; Richard Clapp
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Cancer incidence is rising among adolescents (“teens”). The causes of the increase are unknown but studying incidence patterns and trends may produce insights into etiology. Using data from the US National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program we described trends of cancer incidence among teens (15–19 year olds). We reviewed and summarized incidence patterns for histologic cancer groups and the most frequently diagnosed sites of cancer among teens during 2008–2012 reported by the SEER Cancer Statistics Review. We calculated annual incidence rates for the years 1975–2012 and used linear regression analysis to evaluate trends and calculate rates of change. Incidence for all sites combined increased annually by 0.67% for males and 0.62% for females during the period 1975 through 2012 –resulting in more than a 25% increase over 38 years. The biggest annual incidence increases occurred in non-Hodgkin lymphoma (NHL) (2.16% females; 1.38% males), thyroid cancer (2.12% females; 1.59% males), acute myeloid leukemia (AML) (1.73% females) and testicular cancer (1.55% males). Incidence rates for most histologic groups and sites showed steady long term increases over the 38 years of data. Despite improvements in survival, rising incidence trends mean growing numbers of young adults are undergoing painful and costly cancer treatments. A concerted research program is vital to investigate causes of steadily rising teen cancer rates.

  18. a

    5 year Female Colorectal Cancer Incidence MSSA

    • usc-geohealth-hub-uscssi.hub.arcgis.com
    Updated Nov 12, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Spatial Sciences Institute (2021). 5 year Female Colorectal Cancer Incidence MSSA [Dataset]. https://usc-geohealth-hub-uscssi.hub.arcgis.com/datasets/5-year-female-colorectal-cancer-incidence-mssa
    Explore at:
    Dataset updated
    Nov 12, 2021
    Dataset authored and provided by
    Spatial Sciences Institute
    Area covered
    Description

    Medical Service Study Areas (MSSAs)As defined by California's Office of Statewide Health Planning and Development (OSHPD) in 2013, "MSSAs are sub-city and sub-county geographical units used to organize and display population, demographic and physician data" (Source). Each census tract in CA is assigned to a given MSSA. The most recent MSSA dataset (2014) was used. Spatial data are available via OSHPD at the California Open Data Portal. This information may be useful in studying health equity.Age-Adjusted Incidence Rate (AAIR)Age-adjustment is a statistical method that allows comparisons of incidence rates to be made between populations with different age distributions. This is important since the incidence of most cancers increases with age. An age-adjusted cancer incidence (or death) rate is defined as the number of new cancers (or deaths) per 100,000 population that would occur in a certain period of time if that population had a 'standard' age distribution. In the California Health Maps, incidence rates are age-adjusted using the U.S. 2000 Standard Population.Cancer incidence ratesIncidence rates were calculated using case counts from the California Cancer Registry. Population data from 2010 Census and SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators. Yearly SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators for 5-year incidence rates (2013-2017)According to California Department of Public Health guidelines, cancer incidence rates cannot be reported if based on <15 cancer cases and/or a population <10,000 to ensure confidentiality and stable statistical rates.Spatial extent: CaliforniaSpatial Unit: MSSACreated: n/aUpdated: n/aSource: California Health MapsContact Email: gbacr@ucsf.eduSource Link: https://www.californiahealthmaps.org/?areatype=mssa&address=&sex=Both&site=AllSite&race=&year=05yr&overlays=none&choropleth=Obesity

  19. a

    5 year Kidney Cancer Incidence MSSA

    • usc-geohealth-hub-uscssi.hub.arcgis.com
    Updated Nov 12, 2021
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Spatial Sciences Institute (2021). 5 year Kidney Cancer Incidence MSSA [Dataset]. https://usc-geohealth-hub-uscssi.hub.arcgis.com/datasets/USCSSI::5-year-kidney-cancer-incidence-mssa
    Explore at:
    Dataset updated
    Nov 12, 2021
    Dataset authored and provided by
    Spatial Sciences Institute
    Area covered
    Description

    Medical Service Study Areas (MSSAs)As defined by California's Office of Statewide Health Planning and Development (OSHPD) in 2013, "MSSAs are sub-city and sub-county geographical units used to organize and display population, demographic and physician data" (Source). Each census tract in CA is assigned to a given MSSA. The most recent MSSA dataset (2014) was used. Spatial data are available via OSHPD at the California Open Data Portal. This information may be useful in studying health equity.Age-Adjusted Incidence Rate (AAIR)Age-adjustment is a statistical method that allows comparisons of incidence rates to be made between populations with different age distributions. This is important since the incidence of most cancers increases with age. An age-adjusted cancer incidence (or death) rate is defined as the number of new cancers (or deaths) per 100,000 population that would occur in a certain period of time if that population had a 'standard' age distribution. In the California Health Maps, incidence rates are age-adjusted using the U.S. 2000 Standard Population.Cancer incidence ratesIncidence rates were calculated using case counts from the California Cancer Registry. Population data from 2010 Census and SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators. Yearly SEER 2015 census tract estimates by race/origin (controlling to Vintage 2015) were used to estimate population denominators for 5-year incidence rates (2013-2017)According to California Department of Public Health guidelines, cancer incidence rates cannot be reported if based on <15 cancer cases and/or a population <10,000 to ensure confidentiality and stable statistical rates.Spatial extent: CaliforniaSpatial Unit: MSSACreated: n/aUpdated: n/aSource: California Health MapsContact Email: gbacr@ucsf.eduSource Link: https://www.californiahealthmaps.org/?areatype=mssa&address=&sex=Both&site=AllSite&race=&year=05yr&overlays=none&choropleth=Obesity

  20. G

    Number and rates of new primary cancer cases, by stage at diagnosis,...

    • open.canada.ca
    • www150.statcan.gc.ca
    csv, html, xml
    Updated Jan 26, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statistics Canada (2023). Number and rates of new primary cancer cases, by stage at diagnosis, selected cancer type, age group and sex [Dataset]. https://open.canada.ca/data/en/dataset/ec4efffc-4596-4d73-87f0-f124aa9a8301
    Explore at:
    xml, html, csvAvailable download formats
    Dataset updated
    Jan 26, 2023
    Dataset provided by
    Statistics Canada
    License

    Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
    License information was derived automatically

    Description

    Number and rate of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
National Cancer Institute (NCI), National Institutes of Health (NIH) (2023). Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use [Dataset]. https://catalog.data.gov/dataset/cancer-incidence-surveillance-epidemiology-and-end-results-seer-registries-limited-use
Organization logo

Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use

Explore at:
4 scholarly articles cite this dataset (View in Google Scholar)
Dataset updated
Jul 26, 2023
Dataset provided by
National Cancer Institutehttp://www.cancer.gov/
Description

SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute collects and distributes high quality, comprehensive cancer data from a number of population-based cancer registries. Data include patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage.

Search
Clear search
Close search
Google apps
Main menu